Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG FJ Cordero, Z Huang, C Grenier, X He, G Hu, RE McLendon, SK Murphy, ... Molecular Cancer Research 15 (9), 1243-1254, 2017 | 168 | 2017 |
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy L Wang, Z Zhao, PA Ozark, D Fantini, SA Marshall, EJ Rendleman, ... Nature medicine 24 (6), 758-769, 2018 | 159 | 2018 |
Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma H Katagi, N Louis, D Unruh, T Sasaki, X He, A Zhang, Q Ma, A Piunti, ... Clinical cancer research 25 (18), 5572-5583, 2019 | 73 | 2019 |
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma ST Sredni, AW Bailey, A Suri, R Hashizume, X He, N Louis, T Gokirmak, ... Oncotarget 8 (67), 111190, 2017 | 28 | 2017 |
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model N Louis, S Liu, X He, DC Drummond, CO Noble, S Goldman, S Mueller, ... Journal of Neuro-oncology 136, 475-484, 2018 | 26 | 2018 |
Therapeutic targeting of EZH2 and BET BRD4 in pediatric rhabdoid tumors Y Ishi, Y Zhang, A Zhang, T Sasaki, A Piunti, A Suri, J Watanabe, K Abe, ... Molecular cancer therapeutics 21 (5), 715-726, 2022 | 20 | 2022 |
Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma T Sasaki, J Watanabe, X He, H Katagi, A Suri, Y Ishi, K Abe, M Natsumeda, ... Journal of neurosurgery 138 (6), 1570-1579, 2022 | 6 | 2022 |
ATRT-02. THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN AT/RT A Zhang, A Piunti, P Ozark, X He, H Katagi, T Sasaki, K Laurie, ... Neuro-Oncology 21 (Suppl 2), ii63, 2019 | 2 | 2019 |
Dipg-33. New Therapeutic Approach for Brainstem Glioma: Intranasal Delivery of Nanoliposomal Sn-38 X He, N Louis, H Katagi, P Zhang, I Balyasnikova, C Horbinski, ... Neuro-oncology 20 (suppl_2), i55-i55, 2018 | 2 | 2018 |
PDTM-28. TARGETED INHIBITION OF EZH2 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS A Piunti, M Morgan, E Bartom, N Louis, X He, A Zhang, C Horbinski, ... Neuro-Oncology 19 (suppl_6), vi196-vi196, 2017 | 2 | 2017 |
PDTM-42. TARGETED INHIBITION OF BET BROMODOMAIN AND JMJD3 PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA H Katagi, A Zhang, GT Blyth, FD Eckerdt, PA Ozark, L Zou, X He, ... Neuro-Oncology 20 (Suppl 6), vi212, 2018 | | 2018 |
DIPG-24. TARGETED INHIBITION OF JMJD3 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS H Katagi, N Louis, X He, K Loughlin, A Zhang, P Ozark, C Horbinski, ... Neuro-Oncology 20 (Suppl 2), i53, 2018 | | 2018 |
Radiation DNA damage repair inhibition by GSK-J4 in DIPG N Louis, X He, A Piunti, A Saratsis, R Lulla, J Fangusaro, C Horbinski, ... JOURNAL OF NEUROSURGERY 128 (4), 77-78, 2018 | | 2018 |
PDTM-44. RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG N Louis, X He, A Piunti, M Morgan, D Unruh, A Saratsis, R Lulla, ... Neuro-Oncology 19 (suppl_6), vi199-vi199, 2017 | | 2017 |
PDTM-37. NEW THERAPEUTIC APPROACH FOR BRAINSTEM GLIOMA: INTRANASAL DELIVERY OF NANOLIPOSOMAL SN-38 X He, N Louis, P Zhang, I Balyasnikova, C Horbinski, S Goldman, ... Neuro-Oncology 19 (Suppl 6), vi197, 2017 | | 2017 |
DIPG-36. NOVEL THERAPEUTIC APPROACHES USING NANOLIPOSMAL SN-38 FOR THE TREATMENT OF HUMAN BRAINSTEM GLIOMA X He, N Louis, R Hashizume, P Zhang, I Balyasnikova, C Horbinski, ... Neuro-Oncology 19 (Suppl 4), iv13, 2017 | | 2017 |
DIPG-28. RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG N Louis, X He, A Plunti, A Saratsis, R Lulla, J Fangusaro, C Horbinski, ... Neuro-Oncology 19 (Suppl 4), iv10, 2017 | | 2017 |